Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pure Green CBD for Musculoskeletal Pain
NCT04193631Phase 1Completed
- Sponsor
- Pure Green Pharmaceuticals
- Start
- Dec 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of cannabidiol in Musculoskeletal pain, sponsored by Pure Green Pharmaceuticals. Primary endpoint: Impact of Pure Cannabidiol (CBD) tablets on safety using a self-reported pain scale score at 1 Day. Started Dec 2019; status: completed.
02
Drugs
cannabidiol
03
Conditions
Musculoskeletal pain
Beyond the preview
Go deeper on NCT04193631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04193631.